COTARGETING THE LNCRNA-PIP3 INTERACTION AND AKT/PI3K SIGNALING AXIS: A NOVEL PARADIGM FOR TREATING TRIPLE-NEGATIVE BREAST CANCER

$1,199,811FY2016Department of the ArmyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators